2008
DOI: 10.1016/j.bmc.2008.09.035
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
27
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(29 citation statements)
references
References 44 publications
1
27
0
1
Order By: Relevance
“…Fluoro-substituted tamoxifen and cyclofenol derivatives have been investigated as ER-imaging agents for breast cancer 58,59 and we have previously reported the potent ER-binding properties of fluorine-containing benzoxepine type ER antagonists 30 . We now wished to examine the effect of the inclusion of the lipophilic fluorine substituent on the ER activity of the b-lactam ER antagonist compounds 15b and 15c.…”
mentioning
confidence: 99%
“…Fluoro-substituted tamoxifen and cyclofenol derivatives have been investigated as ER-imaging agents for breast cancer 58,59 and we have previously reported the potent ER-binding properties of fluorine-containing benzoxepine type ER antagonists 30 . We now wished to examine the effect of the inclusion of the lipophilic fluorine substituent on the ER activity of the b-lactam ER antagonist compounds 15b and 15c.…”
mentioning
confidence: 99%
“…So, compounds 3a-e was prepared from 2 by the Mannich reaction (Scheme 1). In another pathway, aldol condensation of the benzoxepin 2 with the appropriate aryl aldehydes in the presence of acidic medium afforded the corresponding 4-benzylidenbenzoxapin-5-ones 4a-d, (Barrett et al, 2008) (Scheme 2). Moreover, selective bromination of the a ketone with copper (II) bromide in On the other hand, the benzoxazepins containing a condensed-ring system of pyridazinone 11a-c were prepared through multistep reactions.…”
Section: Chemistrymentioning
confidence: 99%
“…Although most estrogen target tissues comprise cells expressing both ER isoforms, ERa is predominantly found in reproductive tissues, kidney, liver as well as central nervous system, 9,10 and it is the predominant subtype expressed in breast cancer. 11 On the other hand, ERb is present in many tissues including colon, prostate, testis, ovary, vascular endothelium, and bone. 9,11 There are plenty of examples of subtype-specific compounds 2,4,[9][10][11][12][13][14][15][16][17][18][19][20][21] and recently it has been shown that, for example, raloxifene which is used for the prevention and treatment of osteoporosis, is a relatively ERb-selective SERM.…”
Section: Introductionmentioning
confidence: 99%